AGÕæÈ˹ٷ½

STOCK TITAN

Heartflow to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Heartflow (Nasdaq: HTFL), a leader in AI-powered coronary artery disease technology, has announced its participation in the Morgan Stanley 23rd Annual Global Healthcare Conference. The company's management will engage in a fireside chat scheduled for September 10, 2025, at 6:15 a.m. PT / 9:15 a.m. ET.

Investors can access both live and archived versions of the presentation through Heartflow's Investor Relations website at ir.heartflow.com.

Heartflow (Nasdaq: HTFL), leader nelle tecnologie per la diagnosi della malattia coronarica basate sull'IA, ha annunciato la sua partecipazione alla Morgan Stanley 23rd Annual Global Healthcare Conference. Il management dell'azienda prenderà parte a una conversazione informale (fireside chat) prevista per il 10 settembre 2025 alle 6:15 PT / 9:15 ET.

Gli investitori possono seguire la presentazione in diretta o rivederne la registrazione attraverso il sito Investor Relations di Heartflow all'indirizzo ir.heartflow.com.

Heartflow (Nasdaq: HTFL), líder en tecnología basada en IA para la enfermedad de las arterias coronarias, ha anunciado su participación en la Morgan Stanley 23rd Annual Global Healthcare Conference. La dirección de la compañía participará en una charla (fireside chat) programada para el 10 de septiembre de 2025 a las 6:15 a.m. PT / 9:15 a.m. ET.

Los inversores pueden acceder a la presentación en vivo y a las versiones archivadas a través del sitio de Relaciones con Inversores de Heartflow en ir.heartflow.com.

Heartflow (Nasdaq: HTFL), ì¸ê³µì§€ëŠ� 기반 ê´€ìƒë™ë§� 질환 기술 분야ì� ì„ ë„기업ì� Morgan Stanley 23rd Annual Global Healthcare Conferenceì—� 참가한다ê³� 발표했습니다. 회사 ê²½ì˜ì§„ì€ 2025ë…� 9ì›� 10ì� 오전 6:15 PT / 오전 9:15 ETì—� 예정ë� 파ì´ì–´ì‚¬ì´ë“œ ì±—ì— ì°¸ì„í•� 예정입니ë‹�.

투ìžìžë“¤ì€ Heartflow IR 웹사ì´íЏ ir.heartflow.comì� 통해 발표ì� 실시ê°� ë°� ì•„ì¹´ì´ë¸Œ(녹화) 버전ì—� ì ‘ì†í•� ìˆ� 있습니다.

Heartflow (Nasdaq: HTFL), leader des technologies basées sur l'IA pour les maladies coronariennes, a annoncé sa participation à la Morgan Stanley 23rd Annual Global Healthcare Conference. La direction de l'entreprise prendra part à un entretien informel (fireside chat) prévu le 10 septembre 2025 à 6h15 PT / 9h15 ET.

Les investisseurs peuvent consulter la présentation en direct ou en replay via le site Relations Investisseurs de Heartflow à l'adresse ir.heartflow.com.

Heartflow (Nasdaq: HTFL), ein führendes Unternehmen für KI-gestützte Technologie zur Behandlung koronarer Herzkrankheiten, hat seine Teilnahme an der Morgan Stanley 23rd Annual Global Healthcare Conference angekündigt. Das Management wird an einem Fireside-Chat teilnehmen, der für den 10. September 2025 um 6:15 Uhr PT / 9:15 Uhr ET angesetzt ist.

Investoren können die Präsentation live sowie archiviert über die Investor-Relations-Webseite von Heartflow unter ir.heartflow.com abrufen.

Positive
  • None.
Negative
  • None.

MOUNTAIN VIEW, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that members of management will participate in a fireside chat at the upcoming Morgan Stanley 23rd Annual Global Healthcare Conference. The fireside chat will take place on Wednesday, September 10, 2025, at 6:15 a.m. PT / 9:15 a.m. ET.

A live and archived version of the fireside chat will be available on the Investor Relations section of the Heartflow website at .

About Heartflow, Inc.
Heartflow is advancing coronary care by transforming coronary artery disease into a screenable, diagnosable, and manageable condition. Heartflow One is the only complete, non-invasive, precision coronary care platform providing patient insights throughout the guideline-directed CCTA pathway. The AI-driven platform � including Roadmap� Analysis, FFRCT Analysis and Plaque Analysis � is supported by the ACC/AHA Chest Pain Guideline and backed by more than 600 peer-reviewed publications. Heartflow has helped clinicians manage over 400,000 patients worldwide. Discover how we’re shaping the future of cardiovascular care at .

Investor Contact
Nick Laudico

Media Contact
Elliot Levy


FAQ

When is Heartflow (HTFL) presenting at the Morgan Stanley Healthcare Conference 2025?

Heartflow will present on September 10, 2025, at 6:15 a.m. PT / 9:15 a.m. ET.

Where can I watch Heartflow's Morgan Stanley Conference presentation?

The presentation will be available both live and archived on Heartflow's Investor Relations website at ir.heartflow.com.

What is Heartflow's (HTFL) main business focus?

Heartflow is a leader in AI technology for coronary artery disease (CAD).

What type of presentation will Heartflow give at the Morgan Stanley Healthcare Conference?

Heartflow's management will participate in a fireside chat format presentation.
Heartflow, Inc.

NASDAQ:HTFL

HTFL Rankings

HTFL Latest News

HTFL Latest SEC Filings

HTFL Stock Data

2.48B
16.67M
20.87%
41.4%
Health Information Services
Healthcare
United States
Mountain View